Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: Preliminary report

Acta Neurologica Scandinavica

Volumn 120, Issue 3, 2009, Pages 210-212

  Maschio, M ^a   Dinapoli, L ^a   Saveriano, F ^b   Pompili, A ^a   Carapella, C M ^a   Vidiri, A ^a   Jandolo, B ^a  

^a National Institute for Cancer   (Italy)

^b Clinic of Nervous System Diseases   (Italy)

Author keywords

Antiepileptic drugs; Brain tumor related epilepsy; Zonisamide

Indexed keywords

ETIRACETAM; FOTEMUSTINE; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PREGABALIN; ZONISAMIDE;

ADD ON THERAPY; ADULT; BRAIN TUMOR; BRAIN TUMOR RELATED EPILEPSY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE CONTROL; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; MALE; NOTE; SEXUAL DYSFUNCTION; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTICONVULSANTS; BRAIN NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION;

EID: 69249181627     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01226.x     Document Type: Note

References (15)

1. Schaller B, Rüegg SJ. Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 2003 44 : 1223 1232.
2. Maschio M, Dinapoli L, Zarabla A, Jandolo B. Issues related to the pharmacological management of patients with brain tumours and epilepsy. Funct Neurol 2006 21 : 15 9.
3. Vecht CJ, Van Breemen M. Optimizing therapy of seizures in patients with brain tumors. Neurology 2006 67 (12 Suppl 4 S10 3.
4. Leppik IE. Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure 2004 13 (Suppl 1 S5 9.
5. Baulac M, Leppik IE. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures. Epilepsy Res 2007 75 : 75 83.
6. Coppola G, Grosso S, Verrotti A et al. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study. Epilepsy Res 2009 83 : 112 116.
7. Fisher RS, Van Emde Boas W, Blume W et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005 46 : 470 472. (Pubitemid 40470667)
8. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0, DCTD, NCI, NIH, DHHS, December 12, 2003 (http://ctep.cancer.gov).
9. Taillibert S, Laigle-Donadey F, Sanson M. Palliative care in patients with primary brain tumors. Curr Opin Oncol 2004 16 : 587 592.
10. Mauro AM, Bomprezzi C, Morresi S et al. Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine. J Neurooncol 2007 81 : 279 285.
11. Maschio M, Dinapoli L, Zarabla A et al. Outcome and tolerability of topiramate in brain tumor associated epilepsy. J Neurooncol 2008 86 : 61 70.
12. Maschio M, Albani F, Baruzzi A et al. Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol 2006 80 : 97 100. (Pubitemid 44473268)
13. Newton HB, Goldlust SA, Pearl D. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 2006 78 : 99 102.
14. Novy J, Stupp R, Rossetti AO. Pregabalin in patients with primary brain tumors and seizures: a preliminary observation. Clin Neurol Neurosurg 2009 111 : 171 173.
15. Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitenskyy V, Lucas C. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia 2005 46 : 31 41.